Review





Similar Products

96
Cytoskeleton Inc rhodamine labeled phalloidin working solution
Rhodamine Labeled Phalloidin Working Solution, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rhodamine labeled phalloidin working solution/product/Cytoskeleton Inc
Average 96 stars, based on 1 article reviews
rhodamine labeled phalloidin working solution - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

97
Thermo Fisher alexa488 phalloidin
Alexa488 Phalloidin, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alexa488 phalloidin/product/Thermo Fisher
Average 97 stars, based on 1 article reviews
alexa488 phalloidin - by Bioz Stars, 2026-05
97/100 stars
  Buy from Supplier

96
Beijing Solarbio Science fitc labeled phalloidin
Fitc Labeled Phalloidin, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc labeled phalloidin/product/Beijing Solarbio Science
Average 96 stars, based on 1 article reviews
fitc labeled phalloidin - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

96
Beijing Solarbio Science fitc phalloidin
Fitc Phalloidin, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc phalloidin/product/Beijing Solarbio Science
Average 96 stars, based on 1 article reviews
fitc phalloidin - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

94
MedChemExpress fluorescein phalloidin
Generation of PKM2-overexpressing cells and generation of Tet-PKM2-enriched LEVs. ( A ) Schematic illustration depicting the overexpression of PKM2 in HEK293T cells by lentiviral transduction and subsequent allosteric activation of Tet-PKM2 via TEPP-46 treatment. Cells transfected with ov-NC or ov-PKM2 were named the NC or OV, respectively. ( B ) Relative mRNA expression levels of PKM2 in the NC and OV groups (qRT‒PCR, n = 4). ( C ) Representative immunoblot bands of PKM2 in the NC and OV groups. ( D ) Semiquantitative analysis of the expression levels of PKM2 in the NC and OV groups ( n = 6). ( E ) PK activity in PKM2-overexpressing HEK293T cells in response to treatment with various concentrations of TEPP-46 (0, 10, 20, 40, and 70 μM) ( n = 6). ( F ) Representative immunoblot bands of PKM2 conformational states in PKM2-overexpressing cells after treatment with TEPP-46 (40 μM) for 0, 8, and 24 h (DSS cross-linking assay). ( G ) Semiquantitative analysis of the expression levels of Tet-PKM2 in PKM2-overexpressing cells after treatment with TEPP-46 (40 μM) for 0, 8, and 24 h ( n = 4). ( H ) Schematic illustration of the isolation of LEVs and SEVs by differential velocity centrifugation. ( I ) Representative TEM images showing the morphology of SEVs and LEVs. ( J ) Size distributions of SEVs and LEVs (NTA). ( K ) Particle counts of SEVs and LEVs (NTA). ( L ) Particle-to-protein ratios of SEVs and LEVs. ( M ) Cellular uptake of SEVs and LEVs (labeled with PKH67; green) by macrophages (immunofluorescence assay); cell skeletons were stained with <t>phalloidin</t> (red), and nuclei were stained with DAPI (blue). ( N ) Expression of CD63, HSP70, TSG101, calnexin, and GM130 in whole-cell lysates (Cells), SEVs, and LEVs (Western blot). ( O ) Representative immunoblot bands of PKM2 conformational states in LEVs and SEVs. ( P ) Semiquantitative analysis of the expression levels of Tet-PKM2 in LEVs and SEVs ( n = 3) ( Q ) Conformational states of PKM2 in LEVs Tet−PKM2 in response to TEPP-46 treatment. ( R ) Semiquantitative analysis of the expression levels of Tet-PKM2 in LEVs following TEPP-46 treatment ( n = 3). The data are expressed as the mean ± SEM. Statistical analysis was performed by one-way ANOVA ( E and G ) and Student's t -test ( B , D , K , L , P , and R ). ns indicates no significant difference between the indicated columns; ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 indicate significant differences between the indicated columns.
Fluorescein Phalloidin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluorescein phalloidin/product/MedChemExpress
Average 94 stars, based on 1 article reviews
fluorescein phalloidin - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

96
Cytoskeleton Inc phalloidin
Generation of PKM2-overexpressing cells and generation of Tet-PKM2-enriched LEVs. ( A ) Schematic illustration depicting the overexpression of PKM2 in HEK293T cells by lentiviral transduction and subsequent allosteric activation of Tet-PKM2 via TEPP-46 treatment. Cells transfected with ov-NC or ov-PKM2 were named the NC or OV, respectively. ( B ) Relative mRNA expression levels of PKM2 in the NC and OV groups (qRT‒PCR, n = 4). ( C ) Representative immunoblot bands of PKM2 in the NC and OV groups. ( D ) Semiquantitative analysis of the expression levels of PKM2 in the NC and OV groups ( n = 6). ( E ) PK activity in PKM2-overexpressing HEK293T cells in response to treatment with various concentrations of TEPP-46 (0, 10, 20, 40, and 70 μM) ( n = 6). ( F ) Representative immunoblot bands of PKM2 conformational states in PKM2-overexpressing cells after treatment with TEPP-46 (40 μM) for 0, 8, and 24 h (DSS cross-linking assay). ( G ) Semiquantitative analysis of the expression levels of Tet-PKM2 in PKM2-overexpressing cells after treatment with TEPP-46 (40 μM) for 0, 8, and 24 h ( n = 4). ( H ) Schematic illustration of the isolation of LEVs and SEVs by differential velocity centrifugation. ( I ) Representative TEM images showing the morphology of SEVs and LEVs. ( J ) Size distributions of SEVs and LEVs (NTA). ( K ) Particle counts of SEVs and LEVs (NTA). ( L ) Particle-to-protein ratios of SEVs and LEVs. ( M ) Cellular uptake of SEVs and LEVs (labeled with PKH67; green) by macrophages (immunofluorescence assay); cell skeletons were stained with <t>phalloidin</t> (red), and nuclei were stained with DAPI (blue). ( N ) Expression of CD63, HSP70, TSG101, calnexin, and GM130 in whole-cell lysates (Cells), SEVs, and LEVs (Western blot). ( O ) Representative immunoblot bands of PKM2 conformational states in LEVs and SEVs. ( P ) Semiquantitative analysis of the expression levels of Tet-PKM2 in LEVs and SEVs ( n = 3) ( Q ) Conformational states of PKM2 in LEVs Tet−PKM2 in response to TEPP-46 treatment. ( R ) Semiquantitative analysis of the expression levels of Tet-PKM2 in LEVs following TEPP-46 treatment ( n = 3). The data are expressed as the mean ± SEM. Statistical analysis was performed by one-way ANOVA ( E and G ) and Student's t -test ( B , D , K , L , P , and R ). ns indicates no significant difference between the indicated columns; ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 indicate significant differences between the indicated columns.
Phalloidin, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phalloidin/product/Cytoskeleton Inc
Average 96 stars, based on 1 article reviews
phalloidin - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

96
Cytoskeleton Inc rhodamine labelled f actin
(a) Schematic of pseudo-2D actomyosin network crowded by Methylcellulose on the lipid bilayer. (b) Confocal fluorescence microscopy image of pseudo-2D actomyosin network crosslinked by fascin (top) and α-actinin (bottom) on a supported lipid bilayer. Left is before crosslinking, and right is post crosslinker addition. Scalebar is 5 µm. (c) Kymograph of the yellow dashed line in b), scalebars are 5µm (horizontal) and 10s (vertical). (d) Exemplary linescan intensity (normalized) for conditions in e. (e) Bundling metric λ of fascin and α-actinin crosslinked networks as well <t>as</t> <t>F-actin</t> network without crosslinkers. N = 3 for each condition. (f) Exemplary autocorrelation function of actin network fluctuations as function of lag time Δ t . (g) Characteristic time τ for different conditions. N = 5,3,3,3,3,3 respectively. (h) Confocal fluorescence microscopy image of 2D actomyosin network crosslinked by fascin (top) and α-actinin (bottom) deformed and contracted under myosin active stress over time. Scalebars are 20 µm. Heatmaps show accumulative strain of the final frame. Quiver plot overlay shows the instantaneous velocity. (i) Kymograph of α-actinin network rupture (dashed red line in h). Scalebars are 10µm and 10s. (j) Mean strain < ε > of the network during deformation caused by myosin induced active stress over time. The slope of the strain curve is the strain rate (k) Maximum mean strain < ε > max of fascin and α-actinin crosslinked networks at R c = 0.2. N = 3 for each condition. p fas − aa = 0.0101. (l) Strain rate of the network crosslinked by α-actinin at R c = 0.1 at various myosin concentrations. N = 2,3,3,3,2,2,2 from low to high concentration respectively.
Rhodamine Labelled F Actin, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rhodamine labelled f actin/product/Cytoskeleton Inc
Average 96 stars, based on 1 article reviews
rhodamine labelled f actin - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

Image Search Results


Generation of PKM2-overexpressing cells and generation of Tet-PKM2-enriched LEVs. ( A ) Schematic illustration depicting the overexpression of PKM2 in HEK293T cells by lentiviral transduction and subsequent allosteric activation of Tet-PKM2 via TEPP-46 treatment. Cells transfected with ov-NC or ov-PKM2 were named the NC or OV, respectively. ( B ) Relative mRNA expression levels of PKM2 in the NC and OV groups (qRT‒PCR, n = 4). ( C ) Representative immunoblot bands of PKM2 in the NC and OV groups. ( D ) Semiquantitative analysis of the expression levels of PKM2 in the NC and OV groups ( n = 6). ( E ) PK activity in PKM2-overexpressing HEK293T cells in response to treatment with various concentrations of TEPP-46 (0, 10, 20, 40, and 70 μM) ( n = 6). ( F ) Representative immunoblot bands of PKM2 conformational states in PKM2-overexpressing cells after treatment with TEPP-46 (40 μM) for 0, 8, and 24 h (DSS cross-linking assay). ( G ) Semiquantitative analysis of the expression levels of Tet-PKM2 in PKM2-overexpressing cells after treatment with TEPP-46 (40 μM) for 0, 8, and 24 h ( n = 4). ( H ) Schematic illustration of the isolation of LEVs and SEVs by differential velocity centrifugation. ( I ) Representative TEM images showing the morphology of SEVs and LEVs. ( J ) Size distributions of SEVs and LEVs (NTA). ( K ) Particle counts of SEVs and LEVs (NTA). ( L ) Particle-to-protein ratios of SEVs and LEVs. ( M ) Cellular uptake of SEVs and LEVs (labeled with PKH67; green) by macrophages (immunofluorescence assay); cell skeletons were stained with phalloidin (red), and nuclei were stained with DAPI (blue). ( N ) Expression of CD63, HSP70, TSG101, calnexin, and GM130 in whole-cell lysates (Cells), SEVs, and LEVs (Western blot). ( O ) Representative immunoblot bands of PKM2 conformational states in LEVs and SEVs. ( P ) Semiquantitative analysis of the expression levels of Tet-PKM2 in LEVs and SEVs ( n = 3) ( Q ) Conformational states of PKM2 in LEVs Tet−PKM2 in response to TEPP-46 treatment. ( R ) Semiquantitative analysis of the expression levels of Tet-PKM2 in LEVs following TEPP-46 treatment ( n = 3). The data are expressed as the mean ± SEM. Statistical analysis was performed by one-way ANOVA ( E and G ) and Student's t -test ( B , D , K , L , P , and R ). ns indicates no significant difference between the indicated columns; ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 indicate significant differences between the indicated columns.

Journal: Bioactive Materials

Article Title: Bioengineered extracellular vesicles escape lysosomal degradation and deliver Tet-PKM2 for macrophage immunometabolic reprogramming and periodontitis treatment

doi: 10.1016/j.bioactmat.2026.01.002

Figure Lengend Snippet: Generation of PKM2-overexpressing cells and generation of Tet-PKM2-enriched LEVs. ( A ) Schematic illustration depicting the overexpression of PKM2 in HEK293T cells by lentiviral transduction and subsequent allosteric activation of Tet-PKM2 via TEPP-46 treatment. Cells transfected with ov-NC or ov-PKM2 were named the NC or OV, respectively. ( B ) Relative mRNA expression levels of PKM2 in the NC and OV groups (qRT‒PCR, n = 4). ( C ) Representative immunoblot bands of PKM2 in the NC and OV groups. ( D ) Semiquantitative analysis of the expression levels of PKM2 in the NC and OV groups ( n = 6). ( E ) PK activity in PKM2-overexpressing HEK293T cells in response to treatment with various concentrations of TEPP-46 (0, 10, 20, 40, and 70 μM) ( n = 6). ( F ) Representative immunoblot bands of PKM2 conformational states in PKM2-overexpressing cells after treatment with TEPP-46 (40 μM) for 0, 8, and 24 h (DSS cross-linking assay). ( G ) Semiquantitative analysis of the expression levels of Tet-PKM2 in PKM2-overexpressing cells after treatment with TEPP-46 (40 μM) for 0, 8, and 24 h ( n = 4). ( H ) Schematic illustration of the isolation of LEVs and SEVs by differential velocity centrifugation. ( I ) Representative TEM images showing the morphology of SEVs and LEVs. ( J ) Size distributions of SEVs and LEVs (NTA). ( K ) Particle counts of SEVs and LEVs (NTA). ( L ) Particle-to-protein ratios of SEVs and LEVs. ( M ) Cellular uptake of SEVs and LEVs (labeled with PKH67; green) by macrophages (immunofluorescence assay); cell skeletons were stained with phalloidin (red), and nuclei were stained with DAPI (blue). ( N ) Expression of CD63, HSP70, TSG101, calnexin, and GM130 in whole-cell lysates (Cells), SEVs, and LEVs (Western blot). ( O ) Representative immunoblot bands of PKM2 conformational states in LEVs and SEVs. ( P ) Semiquantitative analysis of the expression levels of Tet-PKM2 in LEVs and SEVs ( n = 3) ( Q ) Conformational states of PKM2 in LEVs Tet−PKM2 in response to TEPP-46 treatment. ( R ) Semiquantitative analysis of the expression levels of Tet-PKM2 in LEVs following TEPP-46 treatment ( n = 3). The data are expressed as the mean ± SEM. Statistical analysis was performed by one-way ANOVA ( E and G ) and Student's t -test ( B , D , K , L , P , and R ). ns indicates no significant difference between the indicated columns; ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 indicate significant differences between the indicated columns.

Article Snippet: PKH67-labeled SEVs and LEVs resuspended in complete medium were used to treat RAW 264.7 cells for 24 h. The cells were then fixed with 4 % PFA (Coolaber), permeabilized, and stained for cytoskeletal visualization using fluorescein phalloidin (1:1000 dilution; MCE) for 30 min.

Techniques: Over Expression, Transduction, Activation Assay, Transfection, Expressing, Western Blot, Activity Assay, Isolation, Centrifugation, Labeling, Immunofluorescence, Staining

(a) Schematic of pseudo-2D actomyosin network crowded by Methylcellulose on the lipid bilayer. (b) Confocal fluorescence microscopy image of pseudo-2D actomyosin network crosslinked by fascin (top) and α-actinin (bottom) on a supported lipid bilayer. Left is before crosslinking, and right is post crosslinker addition. Scalebar is 5 µm. (c) Kymograph of the yellow dashed line in b), scalebars are 5µm (horizontal) and 10s (vertical). (d) Exemplary linescan intensity (normalized) for conditions in e. (e) Bundling metric λ of fascin and α-actinin crosslinked networks as well as F-actin network without crosslinkers. N = 3 for each condition. (f) Exemplary autocorrelation function of actin network fluctuations as function of lag time Δ t . (g) Characteristic time τ for different conditions. N = 5,3,3,3,3,3 respectively. (h) Confocal fluorescence microscopy image of 2D actomyosin network crosslinked by fascin (top) and α-actinin (bottom) deformed and contracted under myosin active stress over time. Scalebars are 20 µm. Heatmaps show accumulative strain of the final frame. Quiver plot overlay shows the instantaneous velocity. (i) Kymograph of α-actinin network rupture (dashed red line in h). Scalebars are 10µm and 10s. (j) Mean strain < ε > of the network during deformation caused by myosin induced active stress over time. The slope of the strain curve is the strain rate (k) Maximum mean strain < ε > max of fascin and α-actinin crosslinked networks at R c = 0.2. N = 3 for each condition. p fas − aa = 0.0101. (l) Strain rate of the network crosslinked by α-actinin at R c = 0.1 at various myosin concentrations. N = 2,3,3,3,2,2,2 from low to high concentration respectively.

Journal: bioRxiv

Article Title: Mechanical organization yields degenerate dissipation beyond linear response

doi: 10.64898/2026.04.22.720181

Figure Lengend Snippet: (a) Schematic of pseudo-2D actomyosin network crowded by Methylcellulose on the lipid bilayer. (b) Confocal fluorescence microscopy image of pseudo-2D actomyosin network crosslinked by fascin (top) and α-actinin (bottom) on a supported lipid bilayer. Left is before crosslinking, and right is post crosslinker addition. Scalebar is 5 µm. (c) Kymograph of the yellow dashed line in b), scalebars are 5µm (horizontal) and 10s (vertical). (d) Exemplary linescan intensity (normalized) for conditions in e. (e) Bundling metric λ of fascin and α-actinin crosslinked networks as well as F-actin network without crosslinkers. N = 3 for each condition. (f) Exemplary autocorrelation function of actin network fluctuations as function of lag time Δ t . (g) Characteristic time τ for different conditions. N = 5,3,3,3,3,3 respectively. (h) Confocal fluorescence microscopy image of 2D actomyosin network crosslinked by fascin (top) and α-actinin (bottom) deformed and contracted under myosin active stress over time. Scalebars are 20 µm. Heatmaps show accumulative strain of the final frame. Quiver plot overlay shows the instantaneous velocity. (i) Kymograph of α-actinin network rupture (dashed red line in h). Scalebars are 10µm and 10s. (j) Mean strain < ε > of the network during deformation caused by myosin induced active stress over time. The slope of the strain curve is the strain rate (k) Maximum mean strain < ε > max of fascin and α-actinin crosslinked networks at R c = 0.2. N = 3 for each condition. p fas − aa = 0.0101. (l) Strain rate of the network crosslinked by α-actinin at R c = 0.1 at various myosin concentrations. N = 2,3,3,3,2,2,2 from low to high concentration respectively.

Article Snippet: Dark G-actin (Cytoskeleton) is mixed with rhodamine labelled F-actin (20% fluorescent, Cytoskeleton) to a final molar concentration of 1.4 μM, and is stabilized with 1 μM phalloidin (Cytoskeleton) and crowded to the surface of a 97% Egg Phosphatidyl Choline (Avanti Polar Lipids)/3% FITC-DHPE (Molecular Probes) phospholipid bilayer, using 0.2% 14,000 MW methyl-cellulose (Sigma, 15 cP) as a depletion agent ( ).

Techniques: Fluorescence, Microscopy, Concentration Assay